首页|期刊导航|中药新药与临床药理|清热化瘀方调控巨噬细胞极化影响子宫内膜异位症进展的作用机制

清热化瘀方调控巨噬细胞极化影响子宫内膜异位症进展的作用机制OA

Mechanism of the Heat-Clearing and Stasis-Resolving Formula in Influencing the Progression of Endometriosis by Regulating Macrophage Polarization

中文摘要英文摘要

目的 探究清热化瘀方通过调控巨噬细胞极化影响子宫内膜异位症(EMs)进展的作用机制.方法 将雌性SD大鼠随机分为清热化瘀组(清热化瘀方颗粒 3.6 g·kg-1)、清热组(清热中药颗粒 0.72 g·kg-1)、化瘀组(化瘀中药颗粒 1.08 g·kg-1)、孕三烯酮组(孕三烯酮 0.45 g·kg-1)及空白组,每组各 6 只,制备含药血清或空白血清.收集临床EMs患者异位病灶样本,分离提取原代人异位内膜间质细胞(HESCs);采用 200 ng·mL-1 佛波脂(PMA)诱导THP-1 细胞 24 h成为M0 巨噬细胞;建立HESCs-巨噬细胞共培养模型,用 20 ng·mL-1 白细胞介素(IL)-4+20 ng·mL-1 IL-13 诱导M0 巨噬细胞 48 h成为M2 型巨噬细胞,同时加入含药血清进行干预.采用CCK-8 法检测细胞增殖活性;流式细胞术检测M1 型巨噬细胞表面标志物CD80 及M2 型巨噬细胞表面标志物CD206 的表达水平;RT-qPCR法检测巨噬细胞TGF-β、TNF-α、IL-10、IL-6 mRNA表达水平;Western Blot法检测巨噬细胞雌激素受体β(ERβ)蛋白表达水平.结果 (1)清热化瘀方、清热中药、化瘀中药含药血清对共培养模型中HESCs增殖活性的抑制作用具有一定浓度依赖性,且 20%清热化瘀方含药血清的抑制作用优于20%清热中药、化瘀中药含药血清(P<0.001),后续实验采用 20%含药血清浓度进行干预.(2)与 20%空白血清组比较,20%孕三烯酮含药血清组、20%清热化瘀方含药血清组、20%化瘀中药含药血清组、20%清热中药含药血清组的M1、M2 型巨噬细胞表面标志物CD80、CD206 表达比例均显著降低(P<0.001),20%清热化瘀方含药血清组、20%化瘀中药含药血清组的CD206/CD80 比值均显著降低(P<0.001);20%清热化瘀方含药血清组的M1 型巨噬细胞分泌因子IL-6、TNF-α及M2 型巨噬细胞分泌因子IL-10、TGF-β的mRNA表达水平均显著降低(P<0.001),20%孕三烯酮含药血清组、20%清热中药含药血清组、20%化瘀中药含药血清组巨噬细胞TNF-α、IL-10、TGF-β mRNA表达水平均显著下降(P<0.05,P<0.01,P<0.001);20%清热化瘀方含药血清组、20%孕三烯酮含药血清组巨噬细胞ERβ蛋白表达明显下调(P<0.05).(3)与 20%清热化瘀方含药血清组比较,20%孕三烯酮含药血清组、20%化瘀中药含药血清组、20%清热中药含药血清组的CD80、CD206 表达比例及CD206/CD80 比值均显著升高(P<0.001);20%孕三烯酮含药血清组巨噬细胞IL-6、IL-10、TNF-α、TGF-β mRNA表达水平均显著升高(P<0.05,P<0.01,P<0.001),20%清热中药含药血清组巨噬细胞IL-10、TNF-α mRNA表达水平明显升高(P<0.05),20%化瘀中药含药血清组巨噬细胞IL-6、TNF-α、TGF-β mRNA表达水平显著升高(P<0.01,P<0.001).(4)与 20%清热中药含药血清组比较,20%化瘀中药含药血清组的CD80、CD206 表达比例及CD206/CD80 比值均显著降低(P<0.001),巨噬细胞IL-10 mRNA表达水平明显降低(P<0.05),TNF-α mRNA表达水平显著升高(P<0.001).结论 清热化瘀方含药血清能够抑制HESCs-巨噬细胞共培养微环境中巨噬细胞向M2 型极化,调控M2/M1 细胞动态平衡,从而抑制HESCs增殖导致的EMs进展,可能与其下调ERβ蛋白表达有关,且清热化瘀方含药血清的作用优于单纯的清热或化瘀中药含药血清.

Objective To investigate the mechanism by which the Heat-Clearing and Stasis-Resolving Formula(HCSRF)affects the progression of endometriosis(EMs)through regulating macrophage polarization.Methods Female SD rats were randomly divided into five groups(n=6 per group):the HCSRF group(granules,3.6 g·kg-1),the Heat-Clearing group(granules,0.72 g·kg-1),the Stasis-Resolving group(granules,1.08 g·kg-1),the gestrinone group(0.45 g·kg-1),and the blank control group,to prepare drug-containing serum or blank serum.Ectopic lesion samples were collected from clinical EMs patients,and primary human ectopic endometrial stromal cells(HESCs)were isolated and extracted.THP-1 cells were induced with 200 ng·mL-1 PMA for 24 hours to differentiate into M0 macrophages.A HESCs-macrophage co-culture model was established.M0 macrophages were induced with 20 ng·mL-1 IL-4+20 ng·mL-1 IL-13 for 48 hours to become M2 macrophages,with simultaneous intervention by drug-containing serum.Cell proliferation activity was detected by the CCK-8 assay.Expression levels of the M1 macrophage surface marker CD80 and the M2 macrophage surface marker CD206 were measured by flow cytometry.mRNA expression levels of TGF-β,TNF-α,IL-10,and IL-6 in macrophages were detected by RT-qPCR.Protein expression of estrogen receptor β(ERβ)in macrophages was detected by Western Blot.Results(1)The inhibitory effects of HCSRF-,Heat-Clearing-,and Stasis-Resolving-drug-containing serum on the proliferation activity of HESCs in the co-culture model showed a certain concentration dependence.The inhibitory effect of 20%HCSRF-containing serum was superior to that of 20%Heat-Clearing-or Stasis-Resolving-containing serum(P<0.001).Therefore,a 20%concentration of drug-containing serum was used for subsequent experiments.(2)Compared with the 20%blank serum group,the expression proportions of the M1 marker CD80 and the M2 marker CD206 were significantly decreased in the 20%gestrinone-,20%HCSRF-,20%Stasis-Resolving-,and 20%Heat-Clearing-containing serum groups(P<0.001).The CD206/CD80 ratio was significantly decreased in the 20%HCSRF-and 20%Stasis-Resolving-containing serum groups(P<0.001).In the 20%HCSRF-containing serum group,mRNA expression levels of the M1-secreted factors IL-6 and TNF-α,as well as the M2-secreted factors IL-10 and TGF-β,were all significantly decreased(P<0.001).In the 20%gestrinone-,20%Heat-Clearing-,and 20%Stasis-Resolving-containing serum groups,mRNA expression levels of TNF-α,IL-10,and TGF-β in macrophages were significantly decreased(P<0.05,P<0.01,P<0.001).ERβ protein expression in macrophages was significantly downregulated in the 20%HCSRF-and 20%gestrinone-containing serum groups(P<0.05).(3)Compared with the 20%HCSRF-containing serum group,the expression proportions of CD80 and CD206,as well as the CD206/CD80 ratio,were significantly increased in the 20%gestrinone-,20%Stasis-Resolving-,and 20%Heat-Clearing-containing serum groups(P<0.001).In the 20%gestrinone-containing serum group,mRNA expression levels of IL-6,IL-10,TNF-α,and TGF-β in macrophages were significantly increased(P<0.05,P<0.01,P<0.001).In the 20%Heat-Clearing-containing serum group,mRNA expression levels of IL-10 and TNF-α in macrophages were significantly increased(P<0.05).In the 20%Stasis-Resolving-containing serum group,mRNA expression levels of IL-6,TNF-α,and TGF-β in macrophages were significantly increased(P<0.01,P<0.001).(4)Compared with the 20%Heat-Clearing-containing serum group,the expression proportions of CD80 and CD206,as well as the CD206/CD80 ratio,were significantly decreased in the 20%Stasis-Resolving-containing serum group(P<0.001).The mRNA expression level of IL-10 was significantly decreased(P<0.05),while that of TNF-α was significantly increased(P<0.001).Conclusion HCSRF-containing serum can inhibit the polarization of macrophages towards the M2 phenotype in the HESCs-macrophage co-culture microenvironment,regulate the M2/M1 cell dynamic balance,thereby inhibiting the progression of EMs caused by HESCs proliferation.This effect may be related to the downregulation of ERβ protein expression.Furthermore,the inhibitory effect of HCSRF-containing serum is superior to that of Heat-Clearing-or Stasis-Resolving-containing serum alone.

丁楠;李盼盼;曹阳;庄梦斐;谭丽;黄圣惠;曾薇薇;张婷婷;孙兆贵

上海中医药大学附属岳阳中西医结合医院,上海 200437上海中医药大学附属岳阳中西医结合医院,上海 200437上海中医药大学附属岳阳中西医结合医院,上海 200437上海中医药大学附属岳阳中西医结合医院,上海 200437上海中医药大学附属岳阳中西医结合医院,上海 200437上海中医药大学附属岳阳中西医结合医院,上海 200437上海中医药大学附属曙光医院,上海 201203上海中医药大学附属岳阳中西医结合医院,上海 200437上海市生物医药技术研究院/国家卫生健康委员会计划生育药具重点实验室,上海 200032

医药卫生

子宫内膜异位症清热化瘀方人异位内膜间质细胞巨噬细胞M2 型极化雌激素受体β大鼠

endometriosisHeat-Clearing and Stasis-Resolving Formulahuman ectopic endometrial stromal cellsmacrophagesM2 polarizationestrogen receptor βrats

《中药新药与临床药理》 2026 (2)

226-234,9

国家自然科学基金项目(82074475,82004398)中医妇科流派上海蔡氏妇科传承创新团队项目(2021LPTD-002)张婷婷教授上海市名老中医学术经验研究工作室项目(SHGZS-2022229)中医妇科专科联盟项目[ZY(2021-2023)0302].

10.19378/j.issn.1003-9783.2026.02.004

评论